We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eisai Files Agreement With Generic Drugmakers

Law360 (October 12, 2007, 12:00 AM EDT) -- Toyko-based drug company Eisai Co. Ltd. has reached a sort of detente with generic drugmakers Mutual Pharmaceuticals Company, Inc. and United Research Laboratories Inc. in a patent dispute over the billion-dollar Alzheimer's treatment Aricept.

Judge Esther Salas signed off on the stipulation and order Wednesday, approving an agreement which says that URL/Mutual will not sell a generic product containing the active ingredient of Aricept, donepezil hydrochloride in the United States until one of three conditions occur.

Either URL/Mutual must give Eisai written notice of its intent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.